Improving colonoscopy follow-up for patients with high risk colon polyps
Official title: Multilevel Health System Intervention to Increase Guideline-Concordant Surveillance Colonoscopy for High Risk Colon Polyps
Run by Jonsson Comprehensive Cancer Center · NCT06376565 · Data updated 2026-11-12
This study is testing whether better reminders and support for scheduling can help patients with high risk colon polyps get their follow-up colonoscopies done on time to lower their chances of developing colorectal cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 1680 (estimated) |
| Sponsor | Jonsson Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | November 8, 2023 |
| Main results expected | November 30, 2027 |
| Study ends | November 30, 2027 |
| Registry record updated | November 14, 2025 |
| Trial ID | NCT06376565 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 45 to 75 who have been diagnosed with high risk neoplasia within the past five years.
✕Probably not a fit
Patients with a personal history of colorectal carcinoma, inflammatory bowel disease, or polyposis syndrome may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial tests a multilevel intervention aimed at enhancing colonoscopy surveillance for patients diagnosed with high risk colon polyps. The study involves interviews with participants and randomization of primary care clinics into two groups: one receiving enhanced reminders and scheduling support for colonoscopy, and the other continuing with standard care practices. The primary goal is to increase the rate of completed surveillance colonoscopies within 3.5 years of high risk neoplasia diagnosis, thereby reducing the risk of colorectal cancer. The intervention includes automated health record updates, patient reminders, and proactive scheduling calls.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the timely detection and prevention of colorectal cancer in high risk patients.
How similar studies have gone: Other studies have shown success with similar multilevel interventions aimed at improving cancer screening adherence, suggesting a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * AIM 1 PATIENTS: Patients between age 45 and 75 with a HRN diagnosis in the past 5 years * AIM 1 PATIENTS: 12 patients who did and 12 patients who did not have surveillance colonoscopy * AIM 1 PROVIDERS: Primary care providers (PCPs) and gastroenterologists (GIs) * AIM 1 ADMINISTRATORS: Administrators who are involved in care processes related to CRC screening, HRN surveillance, and/or colonoscopy scheduling * AIM 2: Patients age 45 to 75 diagnosed with a HRN during the pre-specified two-year HRN diagnosis period Exclusion Criteria: * AIM 2: Individuals with a personal history of colorectal carcinoma (CRC), inflammatory bowel disease (Crohn's, ulcerative colitis), or polyposis syndrome * AIM 2: HRN cases not confirmed by chart review (human-in-the-loop)
Where it's running
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Folasade P May — UCLA / Jonsson Comprehensive Cancer Center
- Study coordinator: Jenna Alarcon
- Email: JCAlarcon@mednet.ucla.edu
- Phone: 310-794-6197
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exercise after pelvic radiation to see if it lowers colorectal cancer risk
This study tests whether regular walking therapy after pelvic radiation for prostate cancer can influence markers of colorectal cancer in colon tissue and blood.
-
Irreversible Electroporation for Recurrent Pelvic Tumors
This study tests whether using irreversible electroporation (IRE) is safe and helps control recurrent pelvic tumors in adults who can’t have other local treatments.
-
Smart Symptom Tracking with ALEX for GI Health in Young Adults
This trial tests whether the Smart Symptom Tracking ALEX app can better track GI symptoms in young adults (18–44) compared with standard paper logs.
-
Culturally adapted online genetic counseling and testing education for African American cancer survivors
We will test a culturally adapted online genetic counseling program to see if it increases genetic counseling and genetic testing among African American breast, prostate, and colorectal cancer survivors.
-
Zanidatamab given before surgery for HER2-positive colon or rectal cancer
This tests whether giving zanidatamab before surgery helps adults with HER2-positive, RAS‑wildtype colon or rectal cancer who are planned for curative treatment.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.